Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list.

Author:

Rault Aude1,Dolbeault Sylvie1,Terrasson Johanna1,Bouleuc Carole1,Cottu Paul1,Piperno-Neumann Sophie1,Rodrigues Manuel1,Vaflard Pauline1,Brédart Anne1ORCID

Affiliation:

1. Institut Curie

Abstract

Abstract

Background Patients' expectations regarding medical information in advanced stages of cancer are still poorly understood in France. Tailoring information to advanced cancer patients is a subtle task. We have developed a question prompt list (QPL), serving as a patient-oncologist communication aid. Methods A four-step sequential mixed-method was followed, involving patients with luminal B/triple-negative metastatic breast cancer or metastatic uveal melanoma (N = 110), patients’ partners, oncologists and researchers (N = 18). In-depth interviews and questionnaires focused on information needed at disclosure of metastasis or resistance to treatment (step 1), formulation of questions and procedures for use in oncology visits (steps 2 and 3), and acceptability of final tool (stage 4). Results The QPL initial version consists of 17 questions covering 5 themes (disease, current treatment, other options, living with cancer, prognosis). In step 2, 13 questions were added, 2 merged and 5 deleted; a short form (4 questions) and recommendations for clinical use were proposed. At step 3, 2 questions were merged and 6 deleted. Four oncologists (27% of the target population) took part in step 4, and the QPL was discussed with 20 patients, revealing a positive appraisal. Conclusion We provide a rigorously developed, relevant, concise and acceptable question prompt list for clinical application in the advanced cancer care setting in France. Further research needs to assess whether this tool actually facilitates the oncologist-patient communication and improves satisfaction with care and health outcomes. Trial registration: The study is listed in ClinicalTrials.gov (NCT04118062) and registered under identification n° IRRID ‘International Registered Report Identifier’: DERR1-10.2196/26414.

Publisher

Springer Science and Business Media LLC

Reference46 articles.

1. Effect of a Patient-Centered Communication Intervention on Oncologist-Patient Communication, Quality of Life, and Health Care Utilization in Advanced Cancer: The VOICE Randomized Clinical Trial;Epstein RM;JAMA Oncol,2017

2. Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced cancer;Enzinger AC;J Clin Oncol,2015

3. Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved;Mack JW;J Clin Oncol,2012

4. Approaching difficult communication tasks in oncology 1;Back AL;CA Cancer J Clin,2005

5. Communicating prognosis in cancer care: a systematic review of the literature;Hagerty R;Ann Oncol,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3